Pharmaceutical compositions for treating depression, anxiety and neurodegenerative disorders

Details for Australian Patent Application No. 2007212586 (hide)

Owner Avanir Pharmaceuticals

Inventors Berg, James

Agent Davies Collison Cave

Pub. Number AU-A-2007212586

PCT Pub. Number WO2007/092329

Priority 60/854,666 26.10.06 US; 60/765,250 03.02.06 US; 60/854,748 27.10.06 US

Filing date 1 February 2007

Wipo publication date 16 August 2007

International Classifications

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Event Publications

28 August 2008 PCT application entered the National Phase

  PCT publication WO2007/092329 Priority application(s): WO2007/092329

30 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007212587-Intravascular device for neuromodulation

2007212583-Inhibition of HIV infection through chemoprophylaxis